Advanced Biopolymer Hydrogels for Targeted Cancer Therapy: From Molecular Design to Controlled Drug Transport and Clinical Translation
Gels · 05.11.2026 · 12 (11) · 1009
DOI: 10.3390/gels12111009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gels, online erschienen am 05.11.2026. Verfasst von Sabuj Chandra Sutradhar und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), funded by the Ministry of Science and ICT, Ministry of Trade, Industry and Energy.
Abstract (Originalsprache)
Biopolymer-based hydrogels offer adaptable platforms for localized cancer therapy by regulating administration, tissue retention, payload protection, and therapeutic release. This review critically examines polysaccharide-, protein-, peptide-, and polynucleotide-based hydrogels, relating polymer composition, crosslinking, network architecture, swelling, degradation, and payload interactions to pharmaceutical and biological performance. Physical, chemical, enzymatic, and ionic gelation strategies are evaluated alongside diffusion-, swelling-, affinity-, and degradation-controlled release and their mathematical interpretation. Macrogels, microgels, nanogels, and hybrid systems are compared according to administration route, disposition, and oncology-relevant function. The review further distinguishes local placement, passive accumulation, ligand-mediated cellular interactions, and endogenous or externally triggered release. Applications in chemotherapy, radiotherapy, immunotherapy, hyperthermia, and phototherapy are assessed across colorectal, gastric, liver, pancreatic, and breast cancers. Marketed devices, patented technologies, clinically evaluated systems, and regulatory considerations are also examined. Despite extensive preclinical development, translation remains constrained by polymer variability, incomplete pharmaceutical characterization, sterilization and scale-up challenges, uncertain degradation and clearance, and limited clinically representative evidence. Progress will depend on clinically defined product design, reproducible manufacturing, quantitative disposition and safety assessment, and demonstration of meaningful benefit over existing therapeutic or procedural alternatives.
Förderung
- National Research Foundation of Korea (NRF), funded by the Ministry of Science and ICT
- Ministry of Trade, Industry and Energy
Zitieren
APA
Sutradhar, S. C., Banik, N., Gun, J. J., Ahmed, M. S., Jang, H., Kim, W., Hasan, M. L., Mazid, M. F. A., Hasan, M. M., Nam, K., & Islam, M. (2026). Advanced Biopolymer Hydrogels for Targeted Cancer Therapy: From Molecular Design to Controlled Drug Transport and Clinical Translation. Gels, 12(11), 1009. https://doi.org/10.3390/gels12111009
Vancouver
Sutradhar SC, Banik N, Gun JJ, Ahmed MS, Jang H, Kim W, et al. Advanced Biopolymer Hydrogels for Targeted Cancer Therapy: From Molecular Design to Controlled Drug Transport and Clinical Translation. Gels. 2026;12(11):1009. doi:10.3390/gels12111009
BibTeX
@article{Sutradhar2026,
author = {Sutradhar, Sabuj Chandra and Banik, Nipa and Gun, Joung Jung and Ahmed, Md. Shahriar and Jang, Hohyoun and Kim, Whangi and Hasan, Md. Lemon and Mazid, Mohammad Faysal Al and Hasan, Md. Mahmudul and Nam, Kyung-Wan and Islam, Mobinul},
title = {Advanced Biopolymer Hydrogels for Targeted Cancer Therapy: From Molecular Design to Controlled Drug Transport and Clinical Translation},
journal = {Gels},
year = {2026},
volume = {12},
number = {11},
pages = {1009},
doi = {10.3390/gels12111009}
}
EUVIMED